Abstract
Serious outcomes after overdose or unintentional exposure to medications used to treat depression rose steadily in the period from 2000 to 2014, with both older and newer drugs contributing to the problem, according to a new study. The study's lead author suggests that many clinicians remain largely unaware of the relative dangers of these medications, including a selective serotonin reuptake inhibitor (SSRI) class that once was believed to result in virtually no morbidity or mortality. Study results were published online Jan. 31 in the American Journal of Psychiatry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
